Japanese Trade Distributors Stock News

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

In July 2026, Fanatec announced a new licensing partnership with Nissan Motor to create officially licensed sim racing steering wheels that mirror Nissan’s performance driving heritage, with further product details to be shared later this year. This collaboration gives Nissan another avenue to showcase its performance brand at home, aligning with its broader push into advanced, experience-focused automotive technology. We’ll now examine how this home-based Nissan performance experience via...

Sumitomo Corp. has completed a share buyback of 33,425,200 shares, around 0.7% of its outstanding stock, for ¥57,305.75 million, and has also agreed to sell its equity stakes in three Belgian offshore wind farms: Nobelwind, Northwester 2, and Northwind. By exiting major offshore wind assets in Belgium while returning capital through buybacks, Sumitomo is materially reshaping how it allocates funds within its broader renewable and infrastructure portfolio. We’ll now examine how Sumitomo’s...

Sanrio Company recently reported full-year results for the year ended March 31, 2026, with sales of ¥194,088,000,000 and net income of ¥54,608,000,000, alongside a dividend of ¥38.00 per share for that year, up from ¥33.00 previously. The company also issued guidance for the year to March 31, 2027, pointing to higher expected sales and profit, while at the same time flagging a significantly lower dividend of ¥8.00 per share, a combination that may prompt investors to reassess how it is...

Japanese financial institutions are sitting at the crossroads of a weak yen, wide interest rate gaps with the U.S., and the possibility of government intervention in currency markets. For investors watching the Japanese yen sit near a multi decade low, this mix of forces could create both pressure and opportunity across banks and insurers. This article focuses on three Japanese Financial Institutions screener stocks that appear strongly tied to these themes, and explains how currency swings...

Tsubakimoto Chain (TSE:6371) has completed a share buyback program, repurchasing 2,399,000 shares, or 2.31% of its stock, for ¥6,203.81 million. This action can reshape per share metrics and ownership dynamics. See our latest analysis for Tsubakimoto Chain. Alongside the completed buyback, Tsubakimoto Chain’s share price has risen 14.06% year to date. The 1 year total shareholder return of 51.63% and 5 year total shareholder return of 188.91% point to building momentum. If this buyback has...

Mitsui O.S.K. Lines (TSE:9104) is back in focus after the board approved changes to its representative directors on June 25, 2026, including new leadership appointments and a high profile retirement. See our latest analysis for Mitsui O.S.K. Lines. The leadership reshuffle comes as Mitsui O.S.K. Lines trades at ¥5,379, with the share price up 3.58% over one day and 2.77% over seven days, but down 7.27% over 30 days and 21.70% over 90 days. Total shareholder return of 18.35% over one year and...

As global markets navigate a mix of economic signals, with the U.S. labor market showing signs of cooling and China's manufacturing sector exhibiting resilience, investors are increasingly attuned to the nuanced dynamics within Asian markets. In this context, identifying promising stocks often involves seeking companies that demonstrate robust fundamentals and adaptability in a shifting economic landscape.

Japan Tobacco (TSE:2914) has drawn fresh attention after Zacks upgraded its rating, citing an upward trend in earnings estimates that points to improving expectations around the company’s underlying business performance and investor sentiment. See our latest analysis for Japan Tobacco. The recent Zacks upgrade comes alongside steady share price gains, with Japan Tobacco’s share price showing a 9.81% year to date return and a 5 year total shareholder return of 284.09%, suggesting momentum has...

China’s latest export controls on Japanese defense and technology companies have pushed supply chain security and rare earth independence back into the spotlight. For investors, this kind of shock can quickly reshape how risk and opportunity are priced across Japanese stocks exposed to the news. This article breaks down what the policy shift might mean for larger domestic supply chain players, and why some of them could see changing expectations around their role in Japan’s push for...

DCM Holdings earnings event and what it means for investors DCM Holdings (TSE:3050) has drawn fresh attention after reporting first quarter results to May 31, 2026, with sales of ¥151,942 million and net income of ¥6,558 million, both higher than a year earlier. See our latest analysis for DCM Holdings. Despite the stronger first quarter figures, DCM Holdings’ recent share price performance has been mixed. The 1-day share price return was 1.01%, but the 90-day share price return declined...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Sompo Holdings (TSE:8630) is back in focus after the company reported progress on its open market share repurchase program, including completion of a ¥9.75b tranche. This has sharpened attention on its capital allocation plans. See our latest analysis for Sompo Holdings. The share buyback update comes after a strong run in Sompo Holdings' stock, with a 1 month share price return of 14.78% and a year to date share price return of 24.63%, alongside a 1 year total shareholder return of 65.55%...

While TOKYO KEIKI INC. ( TSE:7721 ) might not have the largest market cap around , it received a lot of attention from...

Nippon Shinyaku Co., Ltd. recently entered into an option agreement with Elixirgen Therapeutics to potentially secure exclusive worldwide rights to develop and commercialize EXG-7001, an investigational mRNA-based therapy for Duchenne muscular dystrophy that is currently in preclinical development ahead of planned U.S. trials. This move deepens Nippon Shinyaku’s rare-disease focus by targeting full-length dystrophin expression regardless of mutation type, potentially broadening the...

Daiichi Sankyo and AstraZeneca recently secured a European Commission approval for Enhertu across multiple HER2 positive metastatic solid tumors and received an EMA committee recommendation for Datroway as first-line treatment for certain triple-negative breast cancer patients, alongside board decisions on share-based compensation. These oncology milestones expand Daiichi Sankyo’s European treatment footprint, trigger a US$25 million milestone payment from AstraZeneca, and reinforce the...

Sumitomo Mitsui Financial Group recently completed a share repurchase of 17,614,900 shares, or 0.46% of its stock, for ¥108,513.1 million, alongside multiple US dollar fixed-to-floating and floating rate bond issues totaling US$2.75 billion and governance updates including a stock split and dividend approval. Together with fresh Managing Director appointments across key regions and the election of a new director, these actions underscore SMFG’s focus on capital return, funding flexibility,...

Oracle Corporation Japan (TSE:4716) updated investors with new guidance for the year ending May 31, 2027, alongside an increase in its regular dividend and a sizeable special dividend that highlight current shareholder returns. See our latest analysis for Oracle Corporation Japan. At a share price of ¥8,826, Oracle Corporation Japan has recently gained ground with a 1-day share price return of 0.91% and a 7-day share price return of 3.65%. However, the share price return is still down 30.37%...

Mitsui (TSE:8031) is drawing investor attention after increasing its India exposure, targeting semiconductors, e-mobility, and circular economy projects as Japanese investment into the country has reached about $25-35 billion post-COVID. See our latest analysis for Mitsui. At a share price of ¥4,600.0, Mitsui’s short term share price return has weakened, with a 30 day share price return down 8.71% and a 90 day share price return down 27.72%, even as the 1 year total shareholder return of...

Terumo Interventional Systems recently completed the first U.S. procedure using its OPUSWAVE Dual Sensor Imaging System at Mount Sinai Fuster Heart Hospital, combining Optical Frequency Domain Imaging and intravascular ultrasound in a single catheter to enhance intravascular imaging for coronary interventions. This dual-modality platform directly targets physicians’ demand for clearer, real-time vessel visualization and procedural confidence, potentially strengthening Terumo’s position in...

ASKUL (TSE:2678) has just posted its FY 2026 numbers, with fourth quarter revenue of ¥113.3b and a basic EPS loss of ¥90.78, capping a trailing twelve month picture that shows revenue of ¥400.2b and a full year EPS loss of ¥245.40. Over recent periods, the company has seen quarterly revenue move from ¥122.3b in Q4 FY 2025 to ¥113.3b in Q4 FY 2026, while quarterly basic EPS shifted from ¥31.42 to a loss of ¥90.78, underscoring a clear hit to profitability. For investors, these results put...

Investors in Kusuri No Aoki Holdings Co., Ltd. ( TSE:3549 ) had a good week, as its shares rose 5.8% to close at...

Hiday Hidaka (TSE:7611) opened fiscal 2027 with Q1 revenue of ¥16.99b and basic EPS of ¥39.89, setting the tone for a quarter where earnings and top line both sit clearly on the radar for investors watching how the story evolves from here. The company has seen quarterly revenue move from ¥14.67b in Q4 2025 to ¥16.99b in Q1 2027, while basic EPS has shifted from ¥35.46 to ¥39.89 over the same period. These trends now feed into a setup where slightly higher net profit margins put more focus on...

West Japan Railway (TSE:9021) is back in focus after its latest quarterly results delivered an earnings per share surprise of 14.90 ¥ versus an estimated 5.05 ¥, alongside a 3.57% single day stock move. See our latest analysis for West Japan Railway. That earnings surprise has come alongside an 11.48% 1 month share price return, although the 1 year total shareholder return is still down 10.93% and the 5 year total shareholder return is slightly negative, so momentum appears more short term...